Akorn Inc - Company & Market Research Reports

Akorn pharmaceutical is a specialised company that develops niche generic and branded pharmaceuticals, over-the-counter drug products and animal health products internationally and in the U.S. The company was founded in 1971 and is headquartered in Lake Forest, Illinois. The Prescription Pharmaceuticals segment offers generic and branded prescription pharmaceuticals in various dosage forms, including sterile ophthalmics, injectables, and inhalants. The Consumer Health segment manufactures and markets OTC products. This segment offers a portfolio of animal health products, such as Anased and VetaKet veterinary sedatives; Tolazine and Yobine sedative reversing agents; and Butorphic, a pain reliever.


Specialty Generics Market Analysis By Type, By End-use, And Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

Specialty Generics Market Analysis By Type, By End-use, And Segment Forecasts, 2014 - 2025

  • Report
  • 101 Pages
From
Bacterial Conjunctivitis Treatment Market: By Infection; By Antibacterial Class; By Method & By Geography - Forecast 2016-2021 - Product Thumbnail Image

Bacterial Conjunctivitis Treatment Market: By Infection; By Antibacterial Class; By Method & By Geography - Forecast 2016-2021

  • Report
  • 135 Pages
From
Guide to U.S. Specialty Pharmaceutical Market: Companies, Products and Market Data - Product Thumbnail Image

Guide to U.S. Specialty Pharmaceutical Market: Companies, Products and Market Data

  • Report
  • 203 Pages
From
Global Glaucoma Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025 - Product Thumbnail Image

Global Glaucoma Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • Report
From
Europe Artificial Tears Market Research and Forecast 2018-2023 - Product Thumbnail Image

Europe Artificial Tears Market Research and Forecast 2018-2023

  • Report
From
Artificial Tears - Global Strategic Analysis - Product Thumbnail Image

Artificial Tears - Global Strategic Analysis

  • Report
  • 221 Pages
From
Global Glaucoma Treatment Drugs Market Forecast to 2020 - New Product Launches Expected to Boost Market - Product Thumbnail Image

Global Glaucoma Treatment Drugs Market Forecast to 2020 - New Product Launches Expected to Boost Market

  • Report
  • 150 Pages
From
Artificial Tears Market Analysis: By Type; By End-user age group - With Forecast 2016-2021 - Product Thumbnail Image

Artificial Tears Market Analysis: By Type; By End-user age group - With Forecast 2016-2021

  • Report
  • 155 Pages
From
Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report - Product Thumbnail Image

Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report

  • Report
  • 565 Pages
From
Sufentanil Citrate Market: By Applications & By Geography - Forecast 2016-2021 - Product Thumbnail Image

Sufentanil Citrate Market: By Applications & By Geography - Forecast 2016-2021

  • Report
  • 149 Pages
From
Akorn Inc (AKRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Akorn Inc (AKRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • 84 Pages
From
Akorn Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Akorn Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • 50 Pages
From
Akorn Inc (AKRX) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Akorn Inc (AKRX) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • 44 Pages
From
Akorn, Inc. (AKRX) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Akorn, Inc. (AKRX) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • 55 Pages
From
Akorn, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report - Product Thumbnail Image

Akorn, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • Mergers and Acquisitions Profiles
  • 88 Pages
From
Akorn, Inc. - Product Thumbnail Image

Akorn, Inc.

  • Company Profile
  • 69 Pages
Akorn Inc. Company Profile - Business Strategies, Outlook Statement, Business Description, Products and Services, Competitors, Employees, Updates, SWOT and Financials - Product Thumbnail Image

Akorn Inc. Company Profile - Business Strategies, Outlook Statement, Business Description, Products and Services, Competitors, Employees, Updates, SWOT and Financials

  • Company Profile
  • 30 Pages
From
Akorn Inc Strategic Analysis Review - Akorn Inc SWOT, Outlook, Operations and Financial Profile - Product Thumbnail Image

Akorn Inc Strategic Analysis Review - Akorn Inc SWOT, Outlook, Operations and Financial Profile

  • Company Profile
  • 30 Pages
From
Akorn, Inc. Company Profile - Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis - Product Thumbnail Image

Akorn, Inc. Company Profile - Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

  • Company Profile
  • 30 Pages
From
Acquisition of Akorn, Inc. and Merck KGaA’s Biosimilars Business by Fresenius SE & Co. KGaA Call - Fresenius SE & Co. KGaA - Earnings Transcript - Product Thumbnail Image

Acquisition of Akorn, Inc. and Merck KGaA’s Biosimilars Business by Fresenius SE & Co. KGaA Call - Fresenius SE & Co. KGaA - Earnings Transcript

  • Earnings Transcript
Loading Indicator
adroll